Transient Elastography to Assess Hepatic Fibrosis in Hemodialysis Chronic Hepatitis C Patients
Author(s) -
ChenHua Liu,
ChengChao Liang,
KaiWen Huang,
ChunJen Liu,
ShihI Chen,
JouWei Lin,
PeirHaur Hung,
HungBin Tsai,
MingYang Lai,
PeiJer Chen,
Jun-Herng Chen,
DingShinn Chen,
JiaHorng Kao
Publication year - 2011
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.04320510
Subject(s) - medicine , transient elastography , gastroenterology , cirrhosis , hepatic fibrosis , fibrosis , liver biopsy , hemodialysis , receiver operating characteristic , gold standard (test) , stage (stratigraphy) , chronic hepatitis , biopsy , liver fibrosis , virus , immunology , paleontology , biology
Although percutaneous liver biopsy (PLB) is the gold standard for staging hepatic fibrosis in hemodialysis patients with chronic hepatitis C (CHC) before renal transplantation or antiviral therapy, concerns exist about serious postbiopsy complications. Using transient elastography (TE, Fibroscan(®)) to predict the severity of hepatic fibrosis has not been prospectively evaluated in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom